当前位置: 首页 > 期刊 > 《婚育与健康》 > 2023年第16期
编号:594387
小剂量舒芬太尼复合罗哌卡因腰-硬联合麻醉在中老年患者髋关节置换术中的应用
http://www.100md.com 2023年10月1日 婚育与健康 2023年第16期
腰硬联合麻醉,1资料与方法,2结果,3讨论
     余家丽

    【摘要】目的:探究在接受腰硬-联合麻醉的中老年患者髋关节置换术中,小剂量舒芬太尼复合罗哌卡因的应用效果。方法:研究对象为2021年8月—2022年8月在医院接受腰硬联合麻醉下的髋关节置换术治疗的88例中老年患者,随机分为对照组(应用罗哌卡因)和研究组(小剂量舒芬太尼复合罗哌卡因),各44例,观察两种麻醉方案的效果。结果:研究组麻醉优良率高于对照组(P0.05)。结论:小剂量舒芬太尼复合罗哌卡因在腰硬联合麻醉下的中老年髋关节置换术中麻醉优良率高,对血流动力学影响小,无明显不良反应,可推荐应用。

    【关键词】小剂量舒芬太尼;罗哌卡因;腰硬联合麻醉;髋关节置换术

    Application of low-dose sufentanil combined with ropivacaine in hip replacement of middle-aged and elderly patients under combined spinal epidural anesthesia

    YU Jiali

    Qianxinan Traditional Chinese Medicine Hospital, Anesthesiology Department, Qianxinan, Guizhou 562400, China

    【Abstract】Objective: To explore the effect of low-dose sufentanil combined with ropivacaine in hip replacement for middle-aged and elderly patients under combined spinal epidural anesthesia. Methods: The study subjects were 88 middle-aged and elderly patients who received hip replacement under combined spinal and epidural anesthesia in hospital from August 2021 to August 2022. They were randomly divided into a control group (ropivacaine) and a study group (low-dose sufentanil combined with ropivacaine) ......

您现在查看是摘要页,全文长 8683 字符